J.Jpn. Surg. Soc.
ISSN 1880-1129

[Abstract] [Full Text PDF] （in Japanese / 2575KB） [Members Only And Two Factor Auth.]

J.Jpn. Surg. Soc.. 93(9): 972-976, 1992

Report on the annual meeting

THERAPEUTIC INVENTIONS OF PERIOPERATIVE METABOLIC CARE IN DIABETIC PATIENTS

1) First Department of Surgery, Kobe University School of Medicine, Kobe, Japan
2) Second Department of Surgery, Kinki University School of Medicine, Osaka, Japan

Makoto Usami1), Yoichi Saito1), Harumasa Oyanagi2)

Perioperative metabolism was evaluated in diabetic patients and animal models. Experimental model of diabetes mellitus (DM) model was obtained by streptozotocine injection. Each 14C-labeled substrates and combination of carbohydrates mixture was administered intravenously in a dose of 1g/kg before and after laparotomy and cumulative curves of expired 14CO2 was calculated. Biochemical analysis in the liver, blood and urine were performed following infusion of two different solutions, GFX (glucose, fructose, xylitol) solution, 4 : 2 : 1 ratio by weight vs. glucose solution, with 12％ amino acids solution. In a clinical study, incidence of DM in digestive surgery was examined in 3481 cases. Retrospective evaluation of GFX solution was performed in cases after total gastrectomy.
Incidence of DM was 14％ and it has been increased recently, Glucose metabolism in DM rats was disturbed after surgery. Amino acids (alanine and valine) and lipid metabolism was slightly suppressed after surgery in DM rats. The best combination of carbohydrate mixture was determined as GFX solution in animal and clinical experiments. GFX solution improved not only glucose metabolism but also lipid and amino acid metabolism in DM rats. Decreased insulin requirement and increased total calolic intake were observed in DM and borderline DM cases treated by GFX solution.

<< To previous pageTo next page >>

To read the PDF file you will need Adobe Reader installed on your computer.